J. Michael Carruthers is the CFO at ClinOne. Mr. Carruthers has over 20 years of experience in serving as the Chief Financial Officer for publicly-traded pharmaceutical companies.

Mike previously served as Interim President of Nivalis Therapeutics (Nasdaq: NVLS) beginning in January 2017 and Chief Financial Officer and Secretary since February 2015. From December 1998 to February 2015, he served as Chief Financial Officer for Array BioPharma (Nasdaq: ARRY). Prior to this, his professional experience included Chief Financial Officer of Sievers Instrument, treasurer and controller for the Waukesha division of Dover Corporation and accountant with Coopers & Lybrand. Mr. Carruthers received a B.S. in accounting from the University of Colorado and an M.B.A. from the University of Chicago.